Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A Randomized Controlled Trial of Preoperative Prophylactic Antibiotics Prior to Percutaneous Nephrolithotomy in a Low Infectious Risk Population: A Report from the EDGE Consortium1 passage
• Best Practice Statement on Urologic Procedures and Antimicrobial Prophylaxis1 passage
• Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention1 passage
• Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline PART II1 passage
• Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part I1 passage
• Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome1 passage
• Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 20191 passage
• Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)1 passage
• Efficacy and Safety of Prostatic Arterial Embolization: Systematic Review with Meta-Analysis and Meta-Regression1 passage
• Erectile Dysfunction: AUA Guideline1 passage
• Evaluating Benefits of Peristomal Mesh Placement at the Time of Radical Cystectomy and Ileal Conduit Formation: A Phase 3, Randomized Controlled Trial1 passage
• Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia1 passage
• Incidence of Inguinal Hernia after Radical Prostatectomy: A Systematic Review and Meta-Analysis1 passage
• Incidence, Predictive Factors and Preventive Measures for Inguinal Hernia following Robotic and Laparoscopic Radical Prostatectomy: A Systematic Review1 passage
• Incontinence after Prostate Treatment: AUA/SUFU Guideline1 passage
• Is it Safe to Reduce Water Intake in the Overactive Bladder Population? A Systematic Review1 passage
• Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach1 passage
• Male Chronic Pelvic Pain: AUA Guideline: Part II Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome1 passage
• Male Chronic Pelvic Pain: AUA Guideline: Part III Treatment of Chronic Scrotal Content Pain1 passage
• Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management1 passage
• Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part I: Presentation and Evaluation1 passage
• Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part II: Medical Management1 passage
• Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part III: Procedural/Surgical Management1 passage
• Medical Management of Kidney Stones: AUA Guideline (2026) Part I: Evaluation of Patients With Kidney Stones and Dietary Management of Patients With Calcium Stones1 passage
• Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC): A Randomized Clinical Trial1 passage
• Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline1 passage
• Results From the ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) Randomized Controlled Trial1 passage
• Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis1 passage
• Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations1 passage
• Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline1 passage
• Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 20191 passage
• Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 20201 passage
• Systematic Review and Meta-Analysis of the Association between Vitamin D Status and Lower Urinary Tract Symptoms1 passage
• Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic Syndromes1 passage
• The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation1 passage
• The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up1 passage
• The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause1 passage
• The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia1 passage
• Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial1 passage
• Updates to Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2025)1 passage
• Urologic Chronic Pelvic Pain Syndrome Flares: A Comprehensive, Systematic Review and Meta-Analysis of the Peer-Reviewed Flare Literature1 passage
• Vitamin D Repletion in Kidney Stone Formers: A Randomized Controlled Trial1 passage
• WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation(®) vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia1 passage